DRMA (DRMA:NASDAQ) rocketted at $4.87, representing a gain of 16.8%. On Fri, Sep 17, 2021, DRMA:NASDAQ touched a New 2-Week Low of $4.17. From Mon, Sep 13, 2021, the stock recorded 0.00% Up Days and 20.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About DRMA (DRMA:NASDAQ)
Dermata Therapeutics Inc is a clinical-stage biotechnology company. It is focused on the treatment of multiple medical and aesthetic skin conditions and diseases with high unmet needs.
Top 10 Gainers:
- Edesa Biotech, Inc. (EDSA:NASDAQ), 102.72%
- BLNG (BLNG:NASDAQ), 100%
- ARQQ (ARQQ:NASDAQ), 36.58%
- SNTG (SNTG:NASDAQ), 28.8%
- BROS (BROS:NYSE), 18.39%
- DRMA (DRMA:NASDAQ), 16.79%
- Corvus Pharmaceuticals, Inc. (CRVS:NASDAQ), 15.98%
- UCL (UCL:NASDAQ), 14.1%
- Synlogic, Inc. (SYBX:NASDAQ), 12.77%
- SRNG (SRNG:NASDAQ), 12.73%